Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience

Published:2016-08-09 Issue:7 Volume:44 Page:673-683
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Billiet T.¹,Cleynen I.¹,Ballet V.²,Ferrante M.¹²,Van Assche G.¹²,Gils A.³,Vermeire S.¹²

Affiliation:

1. Department of Clinical and Experimental Medicine; Translational Research Center for GastroIntestinal Disorders (TARGID); KU Leuven; Leuven Belgium

2. Department of Gastroenterology and Hepatology; University Hospitals Leuven; KU Leuven; Leuven Belgium

3. Laboratory for Therapeutic and Diagnostic Antibodies; Department of Pharmaceutical and Pharmacological Sciences; KU Leuven; Leuven Belgium

Funder

Fund for Scientific Research Flanders

Meso Scale Diagnostics

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13754/fullpdf

Reference30 articles.

1. Targeting TNF-alpha for the treatment of inflammatory bowel disease;Billiet;Expert Opin Biol Ther,2014

2. Infliximab, azathioprine, or combination therapy for Crohn's disease;Colombel;N Engl J Med,2010

3. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease;Baert;N Engl J Med,2003

4. The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease;Vande Casteele;Gut,2015

5. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease;Vande Casteele;Gastroenterology,2015

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infliximab serum concentrations and disease activity in perianal fistulizing Crohn’s disease: a cross-sectional study;Techniques in Coloproctology;2024-07-20

2. Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes;Advances in Therapy;2024-03-30

3. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14

4. Infliximab serum concentrations and disease activity in perianal fistulizing Crohn's disease: a cross-sectional study;2024-02-28

5. Infliximab for medical induction of remission in Crohn's disease;Cochrane Database of Systematic Reviews;2023-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3